Hardman Johnston Global Advisors LLC Boston Scientific Corp Transaction History

Hardman Johnston Global Advisors LLC

$2.25 Billion
Q4 2024

A detailed history of Hardman Johnston Global Advisors LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Hardman Johnston Global Advisors LLC holds 326,904 shares of BSX stock, worth $32.9 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

326,904

Previous 256,994 27.2%

Holding current value

$32.9 Million

Previous $21.5 Million 35.58%

% of portfolio

1.3%

Previous 0.88%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 04, 2025	BUY	$83.62 - $91.5 $5.85 Million - $6.4 Million	69,910 Added 27.2%	326,904 $29.2 Million
Q3 2024 Oct 30, 2024	SELL	$72.96 - $84.0 $7.12 Million - $8.19 Million	-97,550 Reduced 27.51%	256,994 $21.5 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $20.1 Million - $23.2 Million	-298,070 Reduced 45.67%	354,544 $27.3 Million
Q1 2024 May 06, 2024	SELL	$57.6 - $68.62 $1.29 Million - $1.53 Million	-22,326 Reduced 3.31%	652,614 $44.7 Million
Q4 2023 Jan 29, 2024	BUY	$48.64 - $57.81 $1.21 Million - $1.43 Million	24,810 Added 3.82%	674,940 $39 Million
Q3 2023 Oct 20, 2023	SELL	$50.19 - $54.68 $4.74 Million - $5.16 Million	-94,390 Reduced 12.68%	650,130 $34.3 Million
Q2 2023 Aug 11, 2023	SELL	$49.72 - $54.64 $3.54 Million - $3.89 Million	-71,220 Reduced 8.73%	744,520 $40.3 Million
Q1 2023 May 05, 2023	SELL	$45.09 - $50.03 $157,815 - $175,105	-3,500 Reduced 0.43%	815,740 $40.8 Million
Q4 2022 Feb 03, 2023	SELL	$39.56 - $47.22 $632,168 - $754,575	-15,980 Reduced 1.91%	819,240 $37.9 Million
Q3 2022 Nov 02, 2022	BUY	$36.71 - $109.66 $7.41 Million - $22.1 Million	201,720 Added 31.84%	835,220 $32.3 Million
Q2 2022 Aug 02, 2022	BUY	$35.24 - $47.1 $15,858 - $21,195	450 Added 0.07%	633,500 $23.6 Million
Q1 2022 May 12, 2022	SELL	$40.9 - $45.1 $6.89 Million - $7.59 Million	-168,370 Reduced 21.01%	633,050 $28 Million
Q4 2021 Jan 26, 2022	BUY	$38.07 - $44.87 $138,955 - $163,775	3,650 Added 0.46%	801,420 $34 Million
Q3 2021 Nov 12, 2021	SELL	$41.23 - $45.88 $195,842 - $217,930	-4,750 Reduced 0.59%	797,770 $34.6 Million
Q2 2021 Aug 09, 2021	BUY	$38.58 - $44.24 $736,878 - $844,984	19,100 Added 2.44%	802,520 $34.3 Million
Q1 2021 May 12, 2021	BUY	$35.27 - $39.67 $6.06 Million - $6.81 Million	171,790 Added 28.09%	783,420 $30.3 Million
Q4 2020 Feb 11, 2021	SELL	$33.15 - $41.97 $34,476 - $43,648	-1,040 Reduced 0.17%	611,630 $22 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $2.8 Million - $3.43 Million	81,160 Added 15.27%	612,670 $23.4 Million
Q2 2020 Jul 23, 2020	BUY	$30.19 - $39.11 $8.75 Million - $11.3 Million	289,690 Added 119.8%	531,510 $18.7 Million
Q1 2020 May 04, 2020	BUY	$25.83 - $45.71 $6.25 Million - $11.1 Million	241,820 New	241,820 $7.89 Million

Others Institutions Holding BSX

# of Institutions

1,669

Shares Held

1.22B

Call Options Held

8.76M

Put Options Held

9.42M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $144B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hardman Johnston Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hardman Johnston Global Advisors LLC with notifications on news.

Account

Hardman Johnston Global Advisors LLC Boston Scientific Corp Transaction History